ISRCTN03848493已完成不适用
DHA supplementation to improve maternal, foetal and infant outcomes: is the current recommendation appropriate for women with very low intake and status?
Faculty of Life Sciences and Computing, London Metropolitan University (UK)0 个研究点目标入组 180 人开始时间: 2014年8月20日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Healthy women with singleton pregnancy
排除标准
- •1. Pre-existing chronic medical conditions such as diabetes, high blood pressure, congenital heart disease, kidney disease, very preterm delivery
- •2. Sickle cell disease or hemoglobinopathies
- •3. History of pre-eclampsia, stillbirth or foetal death, major foetal anomaly
- •4. Smoking or other illegal-substance abuse
研究者
相似试验
已完成
不适用
DHA Supplementation and Pregnancy OutcomePregnancyNCT02219399Colorado State University871
Unknown
3 期
A Randomized Trial of Docosahexaenoic Acid Supplementation During Pregnancy to Prevent Deep Placentation DisordersPreeclampsiaFetal Growth RetardationStillbirthPremature BirthNCT02336243Pontificia Universidad Catolica de Chile2,400
已完成
3 期
DHA Supplementation and Pregnancy OutcomePregnancyNCT00266825Susan Carlson, PhD350
已完成
2 期
Effect of Mother DHA Supplementation on Term Newborn.Oxidative StressInflammationInfant DevelopmentNCT01947426Universidad de Granada120
已完成
不适用
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis PigmentosaRetinitis PigmentosaNCT00004827Retina Foundation of the Southwest46